logo

[breadcrumb_custom]

Intellia Therapeutics Inc (NTLA Stock: A Sea of Opportunity

Intellia Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $47.48 on 06/14/23, and the lowest price during the same period was recorded at $22.67 on 11/13/23.

52-week price history of NTLA Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Intellia Therapeutics Inc’s current trading price is -34.67% away from its 52-week high, while its distance from the 52-week low is 36.86%. The stock’s price range during this period has fluctuated between $22.67 and $47.48. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 3.28 million for the day, which was evidently higher than the average daily volume of 1.54 million over the last three months.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Financial Performance and Market Capitalization

Intellia Therapeutics Inc (NTLA) has experienced a quarterly decline of -0.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.98B and boasts a workforce of 526 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 28.09, with a change in price of +1.34. Similarly, Intellia Therapeutics Inc recorded 1,534,724 in trading volume during the last 100 days, posting a change of +4.51%.

NTLA Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NTLA stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.09.

NTLA Stock Stochastic Average

Intellia Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 74.12%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 98.53%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 68.90% and 58.68%, respectively.

NTLA Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 1.74%. However, over the past six months, we’ve seen a stronger performance of -18.90%. The price of NTLA fallen by 25.69% over the last 30 days. And in the last five days, it has surged by 14.25%.

On Key

Related Posts